how to avoid weight gain after stopping semaglutide NOT GLP-1 / (Ozempic, Wegovy, Mounjaro, Zepbound) How To Cope With Post-Ozempic

Ajuda na performance de cardacos que praticam atividades fsicas

Comorbid conditions such as type 2 diabetes, hypertension, or sleep apnea may require indefinite GLP-1 continuation for cardiovascular and metabolic protection independent of weight loss goals

S2CID 44318394

In the UK, there are specific NHS criteria: Semaglutide 2.4mg (Wegovy) : NICE technology appraisal TA875 recommends this only within specialist weight management services and for a maximum of 2 years on the NHS [2] Liraglutide 3.0mg (Saxenda) : NICE technology appraisal TA664 specifies that treatment should only continue beyond 12 weeks if you've lost at least 5% of your initial body weight Clinical trials have demonstrated that most people regain weight after stopping GLP-1 medications

At the same time, SGLT-2 inhibitors are gaining widespread adoption because of their effectiveness in reducing heart failure risks and improving kidney health among diabetic patients

Looker KJ, Magaret AS, Turner KM, Vickerman P, Gottlieb SL, Newman LM